Difficulty with focus can affect work, study, relationships and daily tasks, and it is understandable to look for something that might help when attention deficit hyperactivity disorder (ADHD) symptoms remain difficult to manage. The honest answer is that there is not enough high-quality evidence to say that medical cannabis can improve focus in people with ADHD. Some early studies and patient-reported data have raised questions worth further research, but they do not prove a focus benefit from cannabis-based products for medicinal use (CBPMs). Do not change ADHD medication or self-medicate with cannabis to try to improve focus.¹
Not reliably, based on the evidence available today. The one completed small controlled adult trial did not meet its primary outcome, and observational registry findings show associations with sleep and anxiety rather than established improvement in attention or core ADHD symptoms.
Key Takeaways
- Research has not established medical cannabis as a reliable treatment for focus or core ADHD symptoms.
- The one small controlled adult study did not meet its primary outcome and cannot show a proven attention benefit.
- Observational reports of better sleep, anxiety or quality of life are not proof that focus improved because of CBPM treatment.
- Ongoing concentration problems need a broader ADHD and health review with the relevant clinician.
Why Focus Is Difficult to Measure in ADHD Research
Medical cannabis for ADHD focus needs to be understood in the context of how focus is measured and what influences it. Focus may mean sustained attention, task completion, distractibility, working memory or feeling less overwhelmed, and these are not identical measures. Changes in sleep, anxiety, mood, pain or daily routine can all affect how focused a person feels, without any direct effect on attention itself.
This matters because improvements in sleep or anxiety reported after CBPM use cannot be taken as evidence that focus improved because of the cannabis. Controlled trials using validated attention measures are more reliable than self-reported changes, which can reflect many contributing factors. The evidence needs to be specific to attention rather than assumed from other outcomes.
What Research Has Found So Far
The only completed randomised, placebo-controlled adult trial of a cannabinoid preparation in ADHD, the EMA-C trial, enrolled 30 adults and tested Sativex Oromucosal Spray. The primary outcome was cognitive performance and activity level using the QbTest. Results did not meet significance following adjustment for multiple testing. Some secondary and exploratory outcomes appeared favourable before statistical correction. This does not establish clinical efficacy for focus or any core ADHD symptom.³
A 2023 UK Medical Cannabis Registry analysis in adults with ADHD reported associations with improved anxiety, sleep quality and health-related quality of life at some follow-up points.⁴ It was an observational study. It did not establish that CBPMs improved core ADHD symptoms or focus, and the authors noted the lack of high-quality prospective evidence and long-term outcome data. No evidence in this article should be read as a claim that CBPMs reliably improve attention, executive function, studying, productivity or work performance.
See how ADHD medication and medical cannabis compare.
So, Can Cannabis Help Concentration in ADHD?
It is not possible to say from the current evidence that medical cannabis reliably helps concentration in ADHD. Can cannabis help concentration ADHD is a question many people ask, but the controlled evidence simply does not answer it clearly. The one relevant trial did not meet its primary outcome, and the observational registry data is specific to sleep, anxiety and quality of life, not to concentration or sustained attention.
Some people may report subjective changes in how focused they feel, but individual reports cannot predict another person’s response or replace controlled evidence. Cannabis can also affect alertness, mood, anxiety or concentration in ways that may not be helpful for some people, and any unwanted effect should be raised with a prescribing clinician rather than managed by self-adjustment.
What Else Can Affect Focus?
If concentration remains difficult, there are several clinical factors worth reviewing with the clinician managing ADHD care. These include sleep quality, anxiety, depression, stress, pain, current medication effects, missed doses, alcohol or other substance use, and coexisting health concerns. Work and study demands and changes in daily structure can also affect how focused someone feels.
This does not mean focus problems are a personal failing. It means there may be several treatable or manageable contributors that deserve proper assessment. ADHD treatment often involves more than one element, including review of medication where appropriate, psychological strategies and practical support, as set out in current ADHD management guidance.⁵
When Should Medical Cannabis Be Discussed With a Specialist?
Access of medical cannabis for ADHD focus in the UK is specialist-led, individual and not a guaranteed route for focus problems specifically. Any CBPM discussion follows an individual assessment of diagnosis, symptoms, functional impact, prior treatments, current medicines, mental-health history and safety risks, including driving and machinery responsibilities. You must not drive or operate machinery if you feel drowsy, dizzy or otherwise impaired, regardless of prescription status.¹
LeafEase explains how a specialist assesses medical cannabis for mental health and why suitability is individual.
What to Do If Focus Is Still Affecting Daily Life
If concentration is worsening, side effects are occurring or daily function is falling, arrange a review with the clinician managing your ADHD care. Do not self-adjust prescribed ADHD medication or CBPMs. The appropriate response to treatment that is not helping is a clinical review, not an independent change of product, dose or timing.
Also see what to do when medical cannabis is not helping your ADHD symptoms.
How LeafEase Approaches This
LeafEase uses online eligibility pre-screening, medical-record review and a video consultation with a GMC-registered specialist doctor. If treatment is prescribed, it is dispensed through a licensed UK pharmacy partner with ongoing follow-up care. LeafEase does not diagnose ADHD and does not promise to improve focus. You can see how the LeafEase medical cannabis process works before deciding whether an assessment is worth discussing.
If you have a diagnosed condition, ongoing symptoms and a relevant treatment history, you can check whether a specialist consultation may be appropriate. This first step cannot confirm that a CBPM is suitable or that it will improve focus.
Frequently Asked Questions
Can medical cannabis improve focus in ADHD?
Not reliably, based on current evidence. The one small controlled adult trial did not meet its primary outcome for cognitive performance. Observational registry data shows associations with sleep quality, anxiety and quality of life, not with established improvement in focus or core ADHD symptoms.
Can cannabis help concentration in ADHD?
Some people report subjective changes, but this cannot establish a reliable clinical effect on concentration. Focus is affected by sleep, anxiety, mood, medicines and other factors. Individual reports cannot predict another person’s response or replace controlled clinical evidence.
Is medical cannabis for ADHD focus available in the UK?
A specialist may consider CBPMs where individually clinically appropriate, but ADHD focus medical cannabis UK access is specialist-led, not guaranteed, and is not an established first-line ADHD treatment. A prescription follows a full individual clinical assessment.
Should I stop ADHD medication if I want to explore medical cannabis?
No. Do not change prescribed ADHD medication without the clinician who manages it. Making independent changes to stop, reduce or combine medicines is not safe and does not make a CBPM assessment more likely to be appropriate.
Can medical cannabis make concentration worse?
Effects vary, and unwanted effects can occur. If treatment affects alertness, mood, anxiety or concentration, contact the prescriber and do not drive or operate machinery while impaired. Self-adjusting dose, timing or product is not appropriate.
References
1] GOV.UK (2018) Government announces that medicinal cannabis is legal. Available at: https://www.gov.uk/government/news/government-announces-that-medicinal-cannabis-is-legal Accessed: 8 September 2026].
2] Home Office (2018) Medicinal Cannabis: Home Office Circular 2018. Available at: https://assets.publishing.service.gov.uk/media/5bdb281a40f0b6051ce5df04/Medicinal_Cannabis_-_Home_Office_Circular_2018_FINAL.pdf Accessed: 8 September 2026].
3] Cooper, R.E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J. & Asherson, P. (2017) Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. European Neuropsychopharmacology, 27(8), pp.795-808. Available at: https://doi.org/10.1016/j.euroneuro.2017.05.005 Accessed: 8 September 2026].
4] Ittiphakorn, S. et al. (2023) UK Medical Cannabis Registry: An analysis of clinical outcomes of medical cannabis therapy for attention-deficit/hyperactivity disorder. Neuropsychopharmacology Reports. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10739081/ Accessed: 8 September 2026].
5] National Institute for Health and Care Excellence (2019) Attention deficit hyperactivity disorder: diagnosis and management. NICE Guideline NG87. Available at: https://www.nice.org.uk/guidance/ng87 Accessed: 8 September 2026].
